C07C 317/40
Y being a hydrogen or a carbon atom
C07C317/40 (Y being a hydrogen or a carbon atom) appears on 176 US grants and 163 published applications in this corpus.
Search patents in C07C- Granted patents
- 176
- Published applications
- 163
- Assignees
- 129
- Inventors
- 619
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 3 | 0 |
| 1992 | 4 | 0 |
| 1993 | 6 | 0 |
| 1994 | 4 | 0 |
| 1995 | 4 | 0 |
| 1996 | 9 | 0 |
| 1997 | 4 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 4 | 0 |
| 2001 | 3 | 1 |
| 2002 | 5 | 7 |
| 2003 | 8 | 5 |
| 2004 | 6 | 15 |
| 2005 | 6 | 4 |
| 2006 | 2 | 6 |
| 2007 | 4 | 5 |
| 2008 | 4 | 5 |
| 2009 | 2 | 9 |
| 2010 | 6 | 6 |
| 2011 | 5 | 4 |
| 2012 | 6 | 4 |
| 2013 | 8 | 5 |
| 2014 | 5 | 12 |
| 2015 | 8 | 8 |
| 2016 | 5 | 8 |
| 2017 | 8 | 9 |
| 2018 | 9 | 9 |
| 2019 | 5 | 6 |
| 2020 | 3 | 8 |
| 2021 | 2 | 3 |
| 2022 | 6 | 4 |
| 2023 | 3 | 5 |
| 2024 | 5 | 6 |
| 2025 | 2 | 9 |
| 2026 | 3 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Substituted 3-amino-4-methylbenzenesulfonamides as small molecule inhibitors of ubiquitin-specific protease 2830 Jun 2026US 12,668,571 B2Dana-Farber Cancer Institute, Inc.
- USP30 inhibitors and uses thereof2 Jun 2026US 12,643,852 B2Vincere Biosciences, Inc.
- GPX4 inhibitors, pharmaceutical compositions thereof, and their use for treating GPX4-mediated diseases6 Jan 2026US 12,516,016 B2Eubulus Biotherapeutics (Hong Kong) Limited
- Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto9 Dec 2025US 12,490,741 B2Corteva Agriscience LLC
- Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto25 Mar 2025US 12,256,738 B2Corteva Agriscience LLC
- Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto27 Nov 2025US 2025/0359552 A1Corteva Agriscience LLC
- Ssao inhibitors and use thereof23 Oct 2025US 2025/0326721 A1Eccogene Inc.
- Rxfp1 agonists10 Jul 2025US 2025/0221966 A1Bristol-Myers Squibb Company
- Pcna inhibitors and uses thereof29 May 2025US 2025/0171404 A1City of Hope
- Cysteamides, therapeutic compositions thereof, and related methods22 May 2025US 2025/0161241 A1
Most cited
By later US patents
- Benzamides and related inhibitors of factor Xa155US 7,285,565 B2Millennium Pharmaceuticals, Inc. · 2007
- Benzamides and related inhibitors of factor Xa115US 6,376,515 B2COR Therapeutics, Inc. · 2002
- Benzamides and related inhibitors of factor Xa81US 6,844,367 B1Millennium Pharmaceuticals, Inc. · 2005
- Inhibitors of IMPDH enzyme technical field of the invention73US 6,653,309 B1Vertex Pharmaceuticals Incorporated · 2003
- Reverse hydroxamate inhibitors of matrix metalloproteinases70US 6,235,786 B1Abbott Laboratories · 2001